Characteristics and Outcomes of Children with Cerebral Sinus Venous Thrombosis.


Journal

Neurocritical care
ISSN: 1556-0961
Titre abrégé: Neurocrit Care
Pays: United States
ID NLM: 101156086

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 31 01 2023
accepted: 19 05 2023
medline: 23 10 2023
pubmed: 13 7 2023
entrez: 12 7 2023
Statut: ppublish

Résumé

Cerebral sinus venous thrombosis (CSVT) is an uncommon condition in children with potentially serious outcomes. Large epidemiological studies in children with CSVT are few. The objective of this study is to evaluate the epidemiology and in-hospital outcomes of hospitalized children with CSVT in the United States. We performed a retrospective cross-sectional analysis of the Healthcare Cost and Utilization Project Kids' Inpatient Database for the combined years 2016 and 2019. The database was queried using the diagnoses for intracranial and intraspinal phlebitis and thrombophlebitis, nonpyogenic thrombosis of the intracranial venous system, and cerebral infarction due to cerebral venous thrombosis. Sample weighting was employed to produce national estimates. Of 12,165,621 discharges, 3202 had CSVT (in-hospital prevalence 26.3 per 100,000 discharges). Male patients accounted for 57% of CSVT discharges. The median age was 8 years (interquartile range 1-16), with a U-shaped distribution with peaks in patients younger than 4 years and patients aged between 18 and 20 years. A total of 19.3% of children with CSVT had either hemorrhagic or ischemic stroke. Patients with stroke were more likely to require mechanical ventilation (odds ratio [OR] 2.7; 95% confidence interval [CI] 2.1-3.3; p < 0.001) and have higher mortality (OR 2.3; 95% CI 1.6-3.4; p < 0.001). Mechanical ventilation was necessary for 25.2% of patients with CSVT, of whom the majority were neonates and young children. The need for mechanical ventilation was associated with increased mortality (OR 16.6; 95% CI 9.9-27.9; p < 0.001). The overall mortality rate for CSVT was 4.1%, and 16.5% of patients with CSVT were discharged with home health care or to a skilled nursing facility. CSVT, which has a U-shaped age distribution, is an uncommon condition in children. Stroke is common in children with CSVT, and it is associated with an increased need for mechanical ventilation and increased mortality. The need for mechanical ventilation is more common in infants, and it is associated with increased mortality across all age groups.

Sections du résumé

BACKGROUND BACKGROUND
Cerebral sinus venous thrombosis (CSVT) is an uncommon condition in children with potentially serious outcomes. Large epidemiological studies in children with CSVT are few. The objective of this study is to evaluate the epidemiology and in-hospital outcomes of hospitalized children with CSVT in the United States.
METHODS METHODS
We performed a retrospective cross-sectional analysis of the Healthcare Cost and Utilization Project Kids' Inpatient Database for the combined years 2016 and 2019. The database was queried using the diagnoses for intracranial and intraspinal phlebitis and thrombophlebitis, nonpyogenic thrombosis of the intracranial venous system, and cerebral infarction due to cerebral venous thrombosis. Sample weighting was employed to produce national estimates.
RESULTS RESULTS
Of 12,165,621 discharges, 3202 had CSVT (in-hospital prevalence 26.3 per 100,000 discharges). Male patients accounted for 57% of CSVT discharges. The median age was 8 years (interquartile range 1-16), with a U-shaped distribution with peaks in patients younger than 4 years and patients aged between 18 and 20 years. A total of 19.3% of children with CSVT had either hemorrhagic or ischemic stroke. Patients with stroke were more likely to require mechanical ventilation (odds ratio [OR] 2.7; 95% confidence interval [CI] 2.1-3.3; p < 0.001) and have higher mortality (OR 2.3; 95% CI 1.6-3.4; p < 0.001). Mechanical ventilation was necessary for 25.2% of patients with CSVT, of whom the majority were neonates and young children. The need for mechanical ventilation was associated with increased mortality (OR 16.6; 95% CI 9.9-27.9; p < 0.001). The overall mortality rate for CSVT was 4.1%, and 16.5% of patients with CSVT were discharged with home health care or to a skilled nursing facility.
CONCLUSIONS CONCLUSIONS
CSVT, which has a U-shaped age distribution, is an uncommon condition in children. Stroke is common in children with CSVT, and it is associated with an increased need for mechanical ventilation and increased mortality. The need for mechanical ventilation is more common in infants, and it is associated with increased mortality across all age groups.

Identifiants

pubmed: 37438549
doi: 10.1007/s12028-023-01765-7
pii: 10.1007/s12028-023-01765-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

331-338

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023. Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society.

Références

Ichord RN, Benedict SL, Chan AK, Kirkham FJ, Nowak-Gottl U, International Paediatric Stroke Study G. Paediatric cerebral sinovenous thrombosis: findings of the International Paediatric Stroke Study. Arch Dis Child. 2015;100(2):174–9. https://doi.org/10.1136/archdischild-2014-306382 .
doi: 10.1136/archdischild-2014-306382 pubmed: 25288688
Deveber G, Andrew M, Adams C, et al. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001;345(6):417–23. https://doi.org/10.1056/nejm200108093450604 .
doi: 10.1056/nejm200108093450604 pubmed: 11496852
Grunt S, Wingeier K, Wehrli E, et al. Cerebral sinus venous thrombosis in Swiss children. Dev Med Child Neurol. 2010;52(12):1145–50. https://doi.org/10.1111/j.1469-8749.2010.03722.x .
doi: 10.1111/j.1469-8749.2010.03722.x pubmed: 20573178
Heller C, Heinecke A, Junker R, et al. Cerebral venous thrombosis in children: a multifactorial origin. Circulation. 2003;108(11):1362–7. https://doi.org/10.1161/01.CIR.0000087598.05977.45 .
doi: 10.1161/01.CIR.0000087598.05977.45 pubmed: 12939214
Teksam M, Moharir M, Deveber G, Shroff M. Frequency and topographic distribution of brain lesions in pediatric cerebral venous thrombosis. AJNR Am J Neuroradiol. 2008;29(10):1961–5. https://doi.org/10.3174/ajnr.A1246 .
doi: 10.3174/ajnr.A1246 pubmed: 18687742 pmcid: 8118916
Mallick AA, Sharples PM, Calvert SE, et al. Cerebral venous sinus thrombosis: a case series including thrombolysis. Arch Dis Child. 2009;94(10):790–4. https://doi.org/10.1136/adc.2008.154708 .
doi: 10.1136/adc.2008.154708 pubmed: 19556220
Vieira JP, Luis C, Monteiro JP, et al. Cerebral sinovenous thrombosis in children: clinical presentation and extension, localization and recanalization of thrombosis. Eur J Paediatr Neurol. 2010;14(1):80–5. https://doi.org/10.1016/j.ejpn.2008.12.004 .
doi: 10.1016/j.ejpn.2008.12.004 pubmed: 19201633
Wasay M, Dai AI, Ansari M, Shaikh Z, Roach ES. Cerebral venous sinus thrombosis in children: a multicenter cohort from the United States. J Child Neurol. 2008;23(1):26–31. https://doi.org/10.1177/0883073807307976 .
doi: 10.1177/0883073807307976 pubmed: 18184940
(HCUP) AfHRaQHCaUP. Introduction to the HCUP KIDS’ inpatient database. www.hcup-us.ahrq.gov (2019).
Sabapathy CA, Djouonang TN, Kahn SR, Platt RW, Tagalakis V. Incidence trends and mortality from childhood venous thromboembolism: a population-based cohort study. J Pediatr. 2016;172:175-180 e1. https://doi.org/10.1016/j.jpeds.2016.02.017 .
doi: 10.1016/j.jpeds.2016.02.017 pubmed: 26947569
Sebire G, Tabarki B, Saunders DE, et al. Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain. 2005;128(Pt 3):477–89. https://doi.org/10.1093/brain/awh412 .
doi: 10.1093/brain/awh412 pubmed: 15699061
Deveber G, Monagle P, Chan A, et al. Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol. 1998;55(12):1539. https://doi.org/10.1001/archneur.55.12.1539 .
doi: 10.1001/archneur.55.12.1539 pubmed: 9865798
Dlamini N, Billinghurst L, Kirkham FJ. Cerebral venous sinus (sinovenous) thrombosis in children. Neurosurg Clin N Am. 2010;21(3):511–27. https://doi.org/10.1016/j.nec.2010.03.006 .
doi: 10.1016/j.nec.2010.03.006 pubmed: 20561500 pmcid: 2892748
Sorg AL, Von Kries R, Klemme M, et al. Incidence and risk factors of cerebral sinovenous thrombosis in infants. Dev Med Child Neurol. 2021;63(6):697–704. https://doi.org/10.1111/dmcn.14816 .
doi: 10.1111/dmcn.14816 pubmed: 33506500
Carvalho KS, Bodensteiner JB, Connolly PJ, Garg BP. Cerebral venous thrombosis in children. J Child Neurol. 2001;16(8):574–80. https://doi.org/10.1177/088307380101600807 .
doi: 10.1177/088307380101600807 pubmed: 11510928
Abend NS, Gutierrez-Colina AM, Topjian AA, et al. Nonconvulsive seizures are common in critically ill children. Neurology. 2011;76(12):1071–7. https://doi.org/10.1212/wnl.0b013e318211c19e .
doi: 10.1212/wnl.0b013e318211c19e pubmed: 21307352 pmcid: 3068008
Herman ST, et al. Consensus statement on continuous EEG in critically ill adults and children, part I: indications. J Clin Neurophysiol. 2015;32(2):87–95. https://doi.org/10.1097/WNP.0000000000000166 .
doi: 10.1097/WNP.0000000000000166 pubmed: 25626778 pmcid: 4435533
Lindgren E, Silvis SM, Hiltunen S, et al. Acute symptomatic seizures in cerebral venous thrombosis. Neurology. 2020;95(12):e1706–15. https://doi.org/10.1212/wnl.0000000000010577 .
doi: 10.1212/wnl.0000000000010577 pubmed: 32759191
Ferro JM, Bousser MG, Canhao P, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology. Eur J Neurol. 2017;24(10):1203–13. https://doi.org/10.1111/ene.13381 .
doi: 10.1111/ene.13381 pubmed: 28833980
Ferriero DM, et al. Management of stroke in neonates and children: a scientific statement from the American Heart Association/American Stroke Association. Stroke. 2019;50(3):e51–96. https://doi.org/10.1161/STR.0000000000000183 .
doi: 10.1161/STR.0000000000000183 pubmed: 30686119
Monagle P, et al. American society of hematology 2018 guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018;2(22):3292–316. https://doi.org/10.1182/bloodadvances.2018024786 .
doi: 10.1182/bloodadvances.2018024786 pubmed: 30482766 pmcid: 6258911
Lebas A, et al. EPNS/SFNP guideline on the anticoagulant treatment of cerebral sinovenous thrombosis in children and neonates. Eur J Paediatr Neurol. 2012;16(3):219–28. https://doi.org/10.1016/j.ejpn.2012.02.005 .
doi: 10.1016/j.ejpn.2012.02.005 pubmed: 22425391
Moharir MD, Shroff M, Stephens D, et al. Anticoagulants in pediatric cerebral sinovenous thrombosis: a safety and outcome study. Ann Neurol. 2010;67(5):590–9. https://doi.org/10.1002/ana.21936 .
doi: 10.1002/ana.21936 pubmed: 20437556
Jordan LC, et al. Antithrombotic treatment in neonatal cerebral sinovenous thrombosis: results of the International Pediatric Stroke Study. J Pediatr. 2010;156(5):704–10. https://doi.org/10.1016/j.jpeds.2009.11.061 .
doi: 10.1016/j.jpeds.2009.11.061 pubmed: 20149389 pmcid: 2854210
Faustino EVS, Lawson KA, Northrup V, Higgerson RA. Mortality-adjusted duration of mechanical ventilation in critically ill children with symptomatic central venous line-related deep venous thrombosis*. Crit Care Med. 2011;39(5):1151–6. https://doi.org/10.1097/CCM.0b013e31820eb8a1 .
doi: 10.1097/CCM.0b013e31820eb8a1 pubmed: 21336130 pmcid: 3101274
Sellers A, Meoded A, Quintana J, et al. Risk factors for pediatric cerebral sinovenous thrombosis: a case-control study with case validation. Thromb Res. 2020;194:8–15. https://doi.org/10.1016/j.thromres.2020.06.013 .
doi: 10.1016/j.thromres.2020.06.013 pubmed: 32554256
Fox CK, Johnston SC, Sidney S, Fullerton HJ. High critical care usage due to pediatric stroke: results of a population-based study. Neurology. 2012;79(5):420–7. https://doi.org/10.1212/wnl.0b013e3182616fd7 .
doi: 10.1212/wnl.0b013e3182616fd7 pubmed: 22744664 pmcid: 3405247
Williams CN, Piantino J, Mcevoy C, Fino N, Eriksson CO. The burden of pediatric neurocritical care in the United States. Pediatr Neurol. 2018;89:31–8. https://doi.org/10.1016/j.pediatrneurol.2018.07.013 .
doi: 10.1016/j.pediatrneurol.2018.07.013 pubmed: 30327237 pmcid: 6349248
Hammer J. Acute respiratory failure in children. Paediatr Respir Rev. 2013;14(2):64–9. https://doi.org/10.1016/j.prrv.2013.02.001 .
doi: 10.1016/j.prrv.2013.02.001 pubmed: 23601209
Trachsel D, et al. Developmental respiratory physiology. Paediatr Anaesth. 2022;32(2):108–17. https://doi.org/10.1111/pan.14362 .
doi: 10.1111/pan.14362 pubmed: 34877744
Bushnell CD, Phillips-Bute BG, Laskowitz DT, Lynch JR, Chilukuri V, Borel CO. Survival and outcome after endotracheal intubation for acute stroke. Neurology. 1999;52(7):1374–81. https://doi.org/10.1212/wnl.52.7.1374 .
doi: 10.1212/wnl.52.7.1374 pubmed: 10227620

Auteurs

Juan Sebastian Proaño (JS)

Marshall University Joan C Edwards School of Medicine, 1600 Medical Center Drive, Huntington, WV, 25705, USA. proanocoello@marshall.edu.

Paul A Martinez (PA)

Department of Pediatric Critical Care, Nicklaus Children's Hospital, Miami, USA.
Herbert Wertheim College of Medicine, Florida International University, Miami, USA.

Prithvi Sendi (P)

Department of Pediatric Critical Care, Nicklaus Children's Hospital, Miami, USA.
Herbert Wertheim College of Medicine, Florida International University, Miami, USA.

Balagangadhar R Totapally (BR)

Department of Pediatric Critical Care, Nicklaus Children's Hospital, Miami, USA.
Herbert Wertheim College of Medicine, Florida International University, Miami, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH